Daniel Loeb
Third Point
Daniel Loeb HUMANCO ACQ, CL-A -CW27 stake
total: 588
Third Point HMCOW trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Daniel Loeb doesn't hold any HUMANCO ACQ, CL-A -CW27 (HMCOW) shares. To date, the estimated cost basis is nearly $1.3 for "buy" trades and estimated average "sell" price is $1.06. Third Point first purchased HMCOW in 2021 Q1, initially acquiring 500,000 shares. Since the initial investment in HUMANCO ACQ, CL-A -CW27 (HMCOW), Third Point has made 1 more transaction.
When did Daniel Loeb sell HUMANCO ACQ, CL-A -CW27 (HMCOW)?
Daniel Loeb sold off the entire HUMANCO ACQ, CL-A -CW27 (HMCOW) position in 2021 Q4.
When did Daniel Loeb buy HUMANCO ACQ, CL-A -CW27 (HMCOW)?
Daniel Loeb first invested in HUMANCO ACQ, CL-A -CW27 (HMCOW) in 2021 Q1 at the reported quarter-end price of $1.30 per share.
What's the cost basis of Third Point's HMCOW stake?
The estimated cost basis for HUMANCO ACQ, CL-A -CW27 (HMCOW) stake is around $1.30 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $1.30
- Weighted AVG sell price:
- $1.06
Daniel Loeb's historical trades in HUMANCO ACQ, CL-A -CW27
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$1.06
|
|
-100% (-500,000)
|
-0%
|
|
2021 Q1
|
0.00%
|
500,000
|
$1.30
|
$650,000
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.